🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 21 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/10/2003 | 9,79 | 9,93 | 9,72 | 9,92 | +1,48% | 2,09% | 539.600 |
| 27/10/2003 | 9,54 | 9,84 | 9,54 | 9,78 | +1,77% | 3,09% | 552.600 |
| 24/10/2003 | 9,92 | 9,92 | 9,57 | 9,61 | -2,68% | 3,53% | 538.200 |
| 23/10/2003 | 9,63 | 9,92 | 9,40 | 9,87 | +2,02% | 5,35% | 1.012.600 |
| 22/10/2003 | 10,21 | 10,29 | 9,63 | 9,68 | -5,98% | 6,47% | 716.200 |
| 21/10/2003 | 9,61 | 10,33 | 9,51 | 10,29 | +6,96% | 8,54% | 817.800 |
| 20/10/2003 | 9,90 | 9,97 | 9,60 | 9,62 | -2,58% | 3,74% | 935.600 |
| 17/10/2003 | 10,14 | 10,22 | 9,51 | 9,88 | -2,76% | 7,01% | 1.307.000 |
| 16/10/2003 | 10,55 | 10,62 | 10,15 | 10,16 | -4,42% | 4,45% | 581.000 |
| 15/10/2003 | 11,00 | 11,06 | 10,63 | 10,63 | -3,41% | 3,91% | 296.200 |
| 14/10/2003 | 11,10 | 11,21 | 10,88 | 11,00 | -0,90% | 2,93% | 341.200 |
| 13/10/2003 | 11,25 | 11,30 | 11,10 | 11,10 | -0,09% | 1,78% | 608.600 |
| 10/10/2003 | 11,30 | 11,33 | 11,05 | 11,11 | -1,72% | 2,48% | 554.800 |
| 09/10/2003 | 11,13 | 11,38 | 10,96 | 11,31 | +2,31% | 3,78% | 1.204.600 |
| 08/10/2003 | 11,29 | 11,30 | 10,90 | 11,05 | -1,43% | 3,59% | 1.031.800 |
| 07/10/2003 | 11,36 | 11,37 | 11,13 | 11,21 | -0,93% | 2,16% | 528.600 |
| 06/10/2003 | 11,30 | 11,43 | 11,13 | 11,32 | +0,44% | 2,65% | 554.600 |
| 03/10/2003 | 11,40 | 11,68 | 11,17 | 11,27 | +0,04% | 4,43% | 480.200 |
| 02/10/2003 | 11,15 | 11,37 | 10,94 | 11,26 | +0,45% | 3,86% | 694.800 |
| 01/10/2003 | 11,16 | 11,33 | 11,01 | 11,21 | -0,75% | 2,82% | 644.800 |
| 30/09/2003 | 11,24 | 11,46 | 11,15 | 11,30 | -0,13% | 2,76% | 383.600 |
| 29/09/2003 | 11,23 | 11,33 | 10,80 | 11,31 | +0,27% | 4,67% | 873.400 |
| 26/09/2003 | 11,49 | 11,56 | 11,25 | 11,28 | -1,70% | 2,70% | 580.200 |
| 25/09/2003 | 11,58 | 11,84 | 11,41 | 11,48 | -1,50% | 3,71% | 500.200 |
| 24/09/2003 | 12,14 | 12,16 | 11,54 | 11,65 | -3,52% | 5,11% | 707.200 |
| 23/09/2003 | 11,15 | 12,10 | 10,96 | 12,08 | -0,17% | 10,27% | 2.506.200 |
| 22/09/2003 | 12,31 | 12,36 | 12,09 | 12,10 | -1,87% | 2,19% | 342.400 |
| 19/09/2003 | 12,30 | 12,34 | 12,20 | 12,33 | +0,04% | 1,14% | 320.600 |
| 18/09/2003 | 12,31 | 12,48 | 12,24 | 12,32 | +0,82% | 1,95% | 202.800 |
| 17/09/2003 | 11,99 | 12,50 | 11,99 | 12,22 | +1,12% | 4,21% | 311.600 |